Literature DB >> 18541751

The status of pulmonary arterial hypertension in 2008.

Harrison W Farber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18541751     DOI： 10.1161/CIRCULATIONAHA.108.782979

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  10 in total

1.  Improved pulmonary vascular reactivity and decreased hypertrophic remodeling during nonhypercapnic acidosis in experimental pulmonary hypertension.

Authors:  Helen Christou; Ossama M Reslan; Virak Mam; Alain F Tanbe; Sally H Vitali; Marlin Touma; Elena Arons; S Alex Mitsialis; Stella Kourembanas; Raouf A Khalil
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-01-27       Impact factor: 5.464

2.  Pulmonary arterial hypertension.

Authors:  Sheng Chin Wu; Sergio Caravita; Elisabetta Lisi; Simona Pierini; Viola Dadone; Sarah E Todd; Francesco Gentile; Maria Beatrice Secchi
Journal:  Intern Emerg Med       Date:  2009-12       Impact factor: 3.397

Review 3.  A novel insight into the mechanism of pulmonary hypertension involving caveolin-1 deficiency and endothelial nitric oxide synthase activation.

Authors:  You-Yang Zhao; Asrar B Malik
Journal:  Trends Cardiovasc Med       Date:  2009-10       Impact factor: 6.677

4.  Contribution of oxidative stress to pulmonary arterial hypertension.

Authors:  Vincent G Demarco; Adam T Whaley-Connell; James R Sowers; Javad Habibi; Kevin C Dellsperger
Journal:  World J Cardiol       Date:  2010-10-26

5.  Protein kinase G-I deficiency induces pulmonary hypertension through Rho A/Rho kinase activation.

Authors:  Yidan D Zhao; Lei Cai; Muhammad K Mirza; Xiaojia Huang; Dave L Geenen; Franz Hofmann; Jason X-J Yuan; You-Yang Zhao
Journal:  Am J Pathol       Date:  2012-06       Impact factor: 4.307

6.  Sex hormones and vascular protection in pulmonary arterial hypertension.

Authors:  Helen A Christou; Raouf A Khalil
Journal:  J Cardiovasc Pharmacol       Date:  2010-11       Impact factor: 3.105

7.  Prolyl-4 Hydroxylase 2 (PHD2) Deficiency in Endothelial Cells and Hematopoietic Cells Induces Obliterative Vascular Remodeling and Severe Pulmonary Arterial Hypertension in Mice and Humans Through Hypoxia-Inducible Factor-2α.

Authors:  Zhiyu Dai; Ming Li; John Wharton; Maggie M Zhu; You-Yang Zhao
Journal:  Circulation       Date:  2016-04-25       Impact factor: 29.690

8.  Persistent eNOS activation secondary to caveolin-1 deficiency induces pulmonary hypertension in mice and humans through PKG nitration.

Authors:  You-Yang Zhao; Yidan D Zhao; Muhammad K Mirza; Julia H Huang; Hari-Hara S K Potula; Steven M Vogel; Viktor Brovkovych; Jason X-J Yuan; John Wharton; Asrar B Malik
Journal:  J Clin Invest       Date:  2009-07       Impact factor: 14.808

Review 9.  Endothelial cells in the pathogenesis of pulmonary arterial hypertension.

Authors:  Colin E Evans; Nicholas D Cober; Zhiyu Dai; Duncan J Stewart; You-Yang Zhao
Journal:  Eur Respir J       Date:  2021-09-02       Impact factor: 33.795

Review 10.  A meta-analysis of randomized controlled trials in pulmonary arterial hypertension.

Authors:  Nazzareno Galiè; Alessandra Manes; Luca Negro; Massimiliano Palazzini; Maria Letizia Bacchi-Reggiani; Angelo Branzi
Journal:  Eur Heart J       Date:  2009-01-20       Impact factor: 29.983
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.